Помалидомид Гриндекс

Помалидомид Гриндекс is an oral immunomodulatory agent used in certain blood cancers. This EU-manufactured medication belongs to a class of drugs that help regulate the immune system. Always follow local prescribing guidelines when considering use.

Pomalidomide is primarily used to treat multiple myeloma, a type of blood cancer, in patients who have received prior therapies. It may also be prescribed for other conditions as determined by a healthcare professional. Patients often ask, 'what is pomalidomide used for' when researching treatment options. Its mechanism supports immune system regulation in specific cancer care pathways.

Pomalidomide works by influencing the immune system to slow the growth of cancer cells. Many patients notice improved blood counts over time with consistent use. Some experience mild gastrointestinal effects during early treatment phases. Individual responses vary based on medical history and concurrent therapies.

This medication should only be handled by patients following strict safety protocols due to its potential effects on unborn children. Pregnant individuals or those planning pregnancy must avoid exposure. Always store in a secure location away from children and pets. Consult a healthcare provider about proper handling and disposal methods.

Pomalidomide may interact with other medications that affect the immune system or blood cell production. Strong CYP450 enzyme inhibitors could alter its metabolism, potentially increasing side effects. Alcohol and certain supplements may also interact unpredictably. Always disclose all current medications to your healthcare provider before starting treatment.